IL6 and cancer: The IL-6 inflammatory loop has also been associated with anti-cancer drug resistance through the expansion of CSCs.56,57 We demonstrated that the relative IL-6 expression as determined by ELISA normalised to the proportion of viable cells was reduced after 72 h treatment with doxorubicin only, but not combinatorial DA treatment (p < 0.00001, Fig. 6h).